Dr. McCollum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Dallas, TX 75246Phone+1 214-370-1000Fax+1 214-370-1202
Summary
- Dr. A. David McCollum is an oncologist in Dallas, TX and is affiliated with Texas Oncology with his practice located at the Sammons Cancer Center at Baylor University Medical Center. He received his medical degree from the University of Texas Southwestern Medical School and has been in practice 22 years. He is experienced in the management of gastrointestinal cancers, including hepatobiliary cancers. He has 9 publications and over 500 citings.
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Texas Southwestern Medical CenterChief Residency, Internal Medicine, 1998 - 1999- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Texas Southwestern Medical SchoolClass of 1995
Certifications & Licensure
TX State Medical License 1996 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Pre-op Rectal ChemoRad +/- Cetuximab Start of enrollment: 2007 Feb 01
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
Publications & Presentations
PubMed
- 205 citationsImpact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114Jeffrey A. Meyerhardt, Joel E. Tepper, Donna Niedzwiecki, Donna Hollis, A. David McCollum
Journal of Clinical Oncology. 2004-02-15 - 69 citationsPositron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck ...A. David McCollum, Steven Burrell, Robert I. Haddad, Charles M. Norris, Roy B. Tishler
Head & Neck. 2004-10-01 - 86 citationsLack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.A. David McCollum, Matthew H. Kulke, David P. Ryan, Jeffrey W. Clark, Lawrence N. Shulman
American Journal of Clinical Oncology. 2004-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
